Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Similar documents
Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

Supplement: Summary of Recommendation Statements CHAPTER 1: DEFINITION AND CLASSIFICATION OF CKD

Primary Care Approach to Management of CKD

Evaluation of Chronic Kidney Disease KDIGO. Paul E de Jong University Medical Center Groningen The Netherlands

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

Update on HIV-Related Kidney Diseases. Agenda

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives

Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Diabetic Nephropathy

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Acute renal failure Definition and detection

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Identifying and Managing Chronic Kidney Disease: A Practical Approach

Office Management of Reduced GFR Practical advice for the management of CKD

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH

Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care

Chronic Renal Failure Followed by Acute Renal Failure

Case Studies: Renal and Urologic Impairments Workshop

Updates in Chronic Kidney Disease Management. Delphine S. Tuot, MDCM, MAS Associate Professor of Medicine UCSF-ZSFG

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!

Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward

Faculty/Presenter Disclosure

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153

Early Identification of the Diabetic Nephropathy; Beyond Creatinine

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Chapter 1: CKD in the General Population

Diabetic Nephropathy Larry Lehrner, Ph.D.,M.D.

Section Questions Answers

From Department of Medicine, David Geffen School of Medicine at UCLA.

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist

Life Science Journal 2014;11(10)

What should you do next? Presenter Disclosure Information. Learning Objectives. Case: George

Egfr non african american vs african american

Chronic kidney disease (CKD) has received

Slide #1 Case Presentation: Kidney Disease

CKD IN THE CLINIC. Session Content. Recommendations for commonly used medications in CKD. CKD screening and referral

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

Chronic kidney disease screening and assessment

KEEP Summary Figures S32. Am J Kidney Dis. 2011;57(3)(suppl 2):S32-S56

Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

ASSESSMENT OF A POINT-OF-CARE DEVICE FOR MEASURING CREATININE IN A COMMUNITY SCREENING PROGRAM FOR CHRONIC KIDNEY DISEASE

Clinical guideline Published: 23 July 2014 nice.org.uk/guidance/cg182

Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012

Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA

GFR and Drug Dosage Adaptation: Are We still in the Mist?

Session 9: Optimizing the Management of Patients with Chronic Kidney Disease Learning Objectives

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

Online clinical pathway for chronic kidney disease (CKD) in primary care. February 27, 2015 Dr. Kerry McBrien University of Calgary

Chapter 2 Chronic Kidney Disease (CKD) in Cancer Patients

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

Chronic Kidney Disease: Optimal and Coordinated Management

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

(KFTs) IACLD CME, Monday, February 20, Mohammad Reza Bakhtiari, DCLS, PhD

FREQUENTLY ASKED QUESTIONS ABOUT GFR ESTIMATES

Measurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE

Page 1. Disclosures. Main Points of My Talk. Enlightened Views of Serum Creatinine, egfr, Measured GFR, and the Concept of Clearance

Professor Suetonia Palmer

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018

Creatinine (serum, plasma)

KEEP Summary Figures S40. Am J Kidney Dis. 2012;59(3)(suppl 2):S40-S64


מסקנות מיישום סטנדרטיזציה של בדיקת קראטינין : שימוש בנוסחאות לחישוב egfr

CKD and risk management : NICE guideline

Nephrologists. from. All physicians Patients Health care system Policy makers World health leaders Researchers. Clinical laboratories

Chronic Kidney Disease for the Primary Care Physician in What do the Kidneys do? CKD in the US

23-Jun-15. Albuminuria Renal and Cardiovascular Consequences A history of progress since ,490,000. Kidney Center, UMC Groningen

Early Detection of Chronic Kidney Disease (CKD)

Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review

DEFINITION, CLASSIFICATION AND DIAGNOSIS OF ACUTE KIDNEY INJURY

HHS Public Access Author manuscript Am J Kidney Dis. Author manuscript; available in PMC 2017 July 05.

Department of Clinical Pathology, Faculty of Medicine Padjadjaran University-Dr. Hasan Sadikin General Hospital 2

CARDIO-RENAL SYNDROME

Diabetic Kidney Disease in the Primary Care Clinic

Measurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE

E.Ritz Heidelberg (Germany)

Introduction to Clinical Diagnosis Nephrology

Is CKD prevalence of 10-13% in Europe, US and China a realistic number or is there overdiagnosis of CKD? Marc E De Broe.

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?

Kidney Disease in HIV. Kidney Disease in HIV: An Update for Ryan White Providers

Stages of Chronic Kidney Disease (CKD)

5/10/2014. Observation, control of blood pressure. Observation, control of blood pressure and risk factors.

Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children

Management of early chronic kidney disease

Nephrology referral - Does my patient need it? Disclosure

Predicting and changing the future for people with CKD

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Assessing Renal Function: What you Didn t Know You Didn t Know

Diabetes and Hypertension

National Institute for Health and Care Excellence

Transcription:

Creatinine & egfr A Clinical Perspective Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

CLINICAL CONDITIONS WHERE ASSESSMENT OF GFR IS IMPORTANT Stevens et al. J Am Soc Nephrol 20: 2305 2313, 2009

RATE OF GFR DECLINE IN NORMALS & IN HYPOTHETICAL PATIENTS WITH ONSET OF PROGRESSIVE RENAL DISEASE AT AGE OF 25 YRS Wilmer et al; JASN 14:3217-3232; 2003

DETERMINANTS OF THE SERUM LEVEL OF ENDOGENOUS FILTRATION MARKERS Stevens et al. J Am Soc Nephrol 20: 2305 2313, 2009

DEFINITION CKD is defined as abnormalities of kidney structure or function, present for>3 months, with implications for health Criteria for CKD (either of the following present for >3 months) Albuminuria (AER 30 mg/24 hours; ACR 30 mg/g [ 3 mg/mmol]) Urine sediment abnormalities Electrolyte and other abnormalities due to tubular disorders Abnormalities detected by histology Structural abnormalities detected by imaging History of kidney transplantation Decreased GFR GFR <60 ml/min/1.73 m 2 (GFR categories G3a G5)

Top 4 Etiologies of CKD DM HTN GN PKD illi illi lla lla Year

STAGING 1.2.1: We recommend that CKD is classified based on cause, GFR category, and albuminuria category (CGA). (1B)

EVALUATION OF CHRONICITY In people with GFR <60 ml/min/1.73 m 2 (GFR categories G3a-G5) or markers of kidney damage, review past history and previous measurements to determine duration of kidney disease. (Not Graded) If duration is >3 months, CKD is confirmed. Follow recommendations for CKD If duration is not>3 months or unclear, CKD is not confirmed. Patients may have CKD or acute kidney diseases (including AKI) or both and tests should be repeated accordingly

1.4.3: EVALUATION OF GFR 1.4.3.1: We recommend using serum creatinine and a GFR estimating equation for initial assessment. (1A) 1.4.3.2: We suggest using additional tests (such as cystatin C or a clearance measurement) for confirmatory testing in specific circumstances when egfr based on serum creatinine is less accurate. (2B) 1.4.3.3: We recommend that clinicians (1B): use a GFR estimating equation to derive GFR from serum creatinine (egfrcreat) rather than relying on the serum creatinine concentration alone. understand clinical settings in which egfrcreat is less accurate.

SERUM CREATININE IS NOT A GOOD MEASURE OF EGFR Age Gender Body weight Muscle mass Race Post-operative fluid dilution Rhabdomyolysis Amputations Catabolic scr egfr 1.36 mg/dl 30 ml/min 1.36 mg/dl 130 ml/min Reproduction courtesy of PE Stevens

scr (µmol/l) SERUM CREATININE HIDES EARLY RENAL DAMAGE 600 400 200 5 4 3 2 CKD stage 0 35 70 105 140 egfr (ml/min/1.73m 2 ) Adapted from D Newman

1.4.3: EVALUATION OF GFR 1.4.3.4: We recommend that clinical laboratories should (1B): measure serum creatinine using a specific assay with calibration traceable to the international standard reference materials and minimal bias compared to isotope-dilution mass spectrometry (IDMS) reference methodology. report egfrcreat in addition to the serum creatinine concentration in adults and specify the equation used whenever reporting egfrcreat.

1.4.3: EVALUATION OF GFR 1.4.3.4: We recommend that clinical laboratories should (1B): report egfrcreat in adults using the 2009 CKD-EPI creatinine equation. An alternative creatinine-based GFR estimating equation is acceptable if it has been shown to improve accuracy of GFR estimates compared to the 2009 CKD-EPI creatinine equation. When reporting serum creatinine: We recommend that serum creatinine concentration be reported and rounded to the nearest whole number when expressed as standard international units (lmol/l) and rounded to the nearest 100th of a whole number when expressed as conventional units (mg/dl). When reporting egfrcreat: We recommend that egfrcreat should be reported and rounded to the nearest whole number and relative to a body surface area of 1.73 m 2 in adults using the units ml/min/1.73 m 2. We recommend egfrcreat levels less than 60 ml/min/1.73 m 2 should be reported as decreased.

2009 CKD-EPI CREATININE EQUATION 141 X min(scr/k,1) a X max(scr/k,1 )-1.209 X 0.993 Age [X1.018 if female] [X 1.159 if black] k is 0.7 for females and 0.9 for males a is 0.329 for females and 0.411 for males min is the minimum of SCr/k or 1 max is the maximum of SCr/k or 1

1.4.3.8: We suggest measuring GFR using an exogenous filtration marker under circumstances where more accurate ascertainment of GFR will impact on treatment decisions. (2B)

EVALUATION OF ALBUMINURIA We suggest using the following measurements for initial testing of proteinuria (in descending order of preference, in all cases an early morning urine sample is preferred) (2B): 1) urine albumin-to-creatinine ratio (ACR); 2) urine protein-to-creatinine ratio (PCR); 3) reagent strip urinalysis for total protein with automated reading; 4) reagent strip urinalysis for total protein with manual reading.

1.4.4.2: We recommend that clinical laboratories report ACR and PCR in untimed urine samples in addition to albumin concentration or proteinuria concentrations rather than the concentrations alone. (1B) The term microalbuminuria should no longer be used by laboratories.

Thank You תודה רבה